View Item 

Show simple item record

Loss of β 1 accessory Na + channel subunits causes failure of carbamazepine, but not of lacosamide, in blocking high‐frequency firing via differential effects on persistent Na + currents

dc.contributor.authorUebachs, Mischaen_US
dc.contributor.authorAlbus, Christinaen_US
dc.contributor.authorOpitz, Thoralfen_US
dc.contributor.authorIsom, Lorien_US
dc.contributor.authorNiespodziany, Isabelleen_US
dc.contributor.authorWolff, Christianen_US
dc.contributor.authorBeck, Heinzen_US
dc.date.accessioned2012-12-11T17:37:35Z
dc.date.available2014-01-07T14:51:08Zen_US
dc.date.issued2012-11en_US
dc.identifier.citationUebachs, Mischa; Albus, Christina; Opitz, Thoralf; Isom, Lori; Niespodziany, Isabelle; Wolff, Christian; Beck, Heinz (2012). "Loss of β 1 accessory Na + channel subunits causes failure of carbamazepine, but not of lacosamide, in blocking high‐frequency firing via differential effects on persistent Na + currents." Epilepsia 53(11). <http://hdl.handle.net/2027.42/94523>en_US
dc.identifier.issn0013-9580en_US
dc.identifier.issn1528-1167en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/94523
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherCarbamazepineen_US
dc.subject.otherSodium Channel Beta Subunitsen_US
dc.subject.otherβ 1 Subuniten_US
dc.subject.otherPersistent Sodium Currenten_US
dc.subject.otherI NaPen_US
dc.subject.otherEpilepsyen_US
dc.subject.otherLacosamideen_US
dc.titleLoss of β 1 accessory Na + channel subunits causes failure of carbamazepine, but not of lacosamide, in blocking high‐frequency firing via differential effects on persistent Na + currentsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pharmacology, University of Michigan, Ann Arbor, Michigan, U.S.A.en_US
dc.contributor.affiliationotherDepartment of Epileptology, University of Bonn, Bonn, Germanyen_US
dc.contributor.affiliationotherUCB Pharma, Braine l’Alleud, Belgiumen_US
dc.identifier.pmid23016711en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/94523/1/j.1528-1167.2012.03675.x.pdf
dc.identifier.doi10.1111/j.1528-1167.2012.03675.xen_US
dc.identifier.sourceEpilepsiaen_US
dc.identifier.citedreferenceSekerli M, Negro CAD, Lee RH, Butera RJ. ( 2004 ) Estimating action potential thresholds from neuronal time‐series: new metrics and evaluation of methodologies. IEEE Trans Biomed Eng 51: 1665 – 1672.en_US
dc.identifier.citedreferenceWallace RH, Wang DW, Singh R, Scheffer IE, George A Jr, Phillips HA, Saar K, Reis A, Johnson EW, Sutherland GR, Berkovic SF, Mulley JC. ( 1998 ) Febrile seizures and generalized epilepsy associated with a mutation in the Na + ‐channel beta1 subunit gene SCN1B. Nat Genet 19: 366 – 370.en_US
dc.identifier.citedreferenceChen C, Westenbroek RE, Xu X, Edwards CA, Sorenson DR, Chen Y, McEwen DP, O’Malley HA, Bharucha V, Meadows LS, Knudsen GA, Vilaythong A, Noebels JL, Saunders TL, Scheuer T, Shrager P, Catterall WA, Isom LL. ( 2004 ) Mice lacking sodium channel beta1 subunits display defects in neuronal excitability sodium channel expression and nodal architecture. J Neurosci 24: 4030 – 4042.en_US
dc.identifier.citedreferenceCross SA, Curran MP. ( 2009 ) Lacosamide: in partial‐onset seizures. Drugs 69: 449 – 459.en_US
dc.identifier.citedreferenceDuncan GE, Kohn H. ( 2005 ) The novel antiepileptic drug lacosamide blocks behavioral and brain metabolic manifestations of seizure activity in the 6 Hz psychomotor seizure model. Epilepsy Res 67: 81 – 87.en_US
dc.identifier.citedreferenceEllerkmann RK, Remy S, Chen J, Sochivko D, Elger CE, Urban BW, Becker A, Beck H. ( 2003 ) Molecular and functional changes in voltage‐dependent Na + channels following pilocarpine‐induced status epilepticus in rat dentate granule cells. Neuroscience 119: 323 – 333.en_US
dc.identifier.citedreferenceErrington AC, Stöhr T, Heers C, Lees G. ( 2008 ) The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage‐gated sodium channels. Mol Pharmacol 73: 157 – 169.en_US
dc.identifier.citedreferenceGastaldi M, Robaglia‐Schlupp A, Massacrier A, Planells R, Cau P. ( 1998 ) mRNA coding for voltage‐gated sodium channel beta2 subunit in rat central nervous system: cellular distribution and changes following kainate‐induced seizures. Neurosci Lett 249: 53 – 56.en_US
dc.identifier.citedreferenceGreenaway C, Ratnaraj N, Sander JW, Patsalos PN. ( 2011 ) Saliva and serum lacosamide concentrations in patients with epilepsy. Epilepsia 52: 258 – 263.en_US
dc.identifier.citedreferenceKazen‐Gillespie KA, Ragsdale DS, D’Andrea MR, Mattei LN, Rogers KE, Isom LL. ( 2000 ) Cloning localization and functional expression of sodium channel beta1A subunits. J Biol Chem 275: 1079 – 1088.en_US
dc.identifier.citedreferenceKellinghaus C. ( 2009 ) Lacosamide as treatment for partial epilepsy: mechanisms of action, pharmacology, effects, and safety. Ther Clin Risk Manag 5: 757 – 766.en_US
dc.identifier.citedreferenceKuo CC, Huang RC, Lou BS. ( 2000 ) Inhibition of Na + current by diphenhydramine and other diphenyl compounds: molecular determinants of selective binding to the inactivated channels. Mol Pharmacol 57: 135 – 143.en_US
dc.identifier.citedreferenceLees G, Stöhr T, Errington AC. ( 2006 ) Stereoselective effects of the novel anticonvulsant lacosamide against 4‐AP induced epileptiform activity in rat visual cortex in vitro. Neuropharmacology 50: 98 – 110.en_US
dc.identifier.citedreferenceMeadows LS, Malhotra J, Loukas A, Thyagarajan V, Kazen‐Gillespie KA, Koopman MC, Kriegler S, Isom LL, Ragsdale DS. ( 2002 ) Functional and biochemical analysis of a sodium channel beta1 subunit mutation responsible for generalized epilepsy with febrile seizures plus type 1. J Neurosci 22: 10699 – 10709.en_US
dc.identifier.citedreferenceMüller A, Kukley M, Uebachs M, Beck H, Dietrich D. ( 2007 ) Nanodomains of single Ca 2+ channels contribute to action potential repolarization in cortical neurons. J Neurosci 27: 483 – 495.en_US
dc.identifier.citedreferenceNicot A, Ratnakar PV, Ron Y, Chen CC, Elkabes S. ( 2003 ) Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction. Brain 126: 398 – 412.en_US
dc.identifier.citedreferencePatino GA, Claes LRF, Lopez‐Santiago LF, Slat EA, Dondeti RSR, Chen C, O’Malley HA, Gray CBB, Miyazaki H, Nukina N, Oyama F, Jonghe PD, Isom LL. ( 2009 ) A functional null mutation of SCN1B in a patient with Dravet syndrome. J Neurosci 29: 10764 – 10778.en_US
dc.identifier.citedreferenceRagsdale DS, McPhee JC, Scheuer T, Catterall WA. ( 1996 ) Common molecular determinants of local anesthetic antiarrhythmic and anticonvulsant block of voltage‐gated Na + channels. Proc Natl Acad Sci USA 93: 9270 – 9275.en_US
dc.identifier.citedreferenceSashihara S, Greer CA, Oh Y, Waxman SG. ( 1996 ) Cell‐specific differential expression of Na + ‐channel beta 1‐subunit mRNA in the olfactory system during postnatal development and after denervation. J Neurosci 16: 702 – 713.en_US
dc.identifier.citedreferenceSchaub C, Uebachs M, Beck H. ( 2007 ) Diminished response of CA1 neurons to antiepileptic drugs in chronic epilepsy. Epilepsia 48: 1339 – 1350.en_US
dc.identifier.citedreferenceSheets PL, Heers C, Stoehr T, Cummins TR. ( 2008 ) Differential block of sensory neuronal voltage‐gated sodium channels by lacosamide [(2R)‐2‐(acetylamino)‐N‐benzyl‐3‐methoxypropanamide] lidocaine and carbamazepine. J Pharmacol Exp Ther 326: 89 – 99.en_US
dc.identifier.citedreferenceStöhr T, Kupferberg HJ, Stables JP, Choi D, Harris RH, Kohn H, Walton N, White HS. ( 2007 ) Lacosamide a novel anti‐convulsant drug shows efficacy with a wide safety margin in rodent models for epilepsy. Epilepsy Res 74: 147 – 154.en_US
dc.identifier.citedreferenceSun GC, Werkman TR, Battefeld A, Clare JJ, Wadman WJ. ( 2007 ) Carbamazepine and topiramate modulation of transient and persistent sodium currents studied in HEK293 cells expressing Na V 1.3 alpha‐subunit. Epilepsia 48: 774 – 782.en_US
dc.identifier.citedreferenceTaverna S, Mantegazza M, Franceschetti S, Avanzini G. ( 1998 ) Valproate selectively reduces the persistent fraction of Na + current in neocortical neurons. Epilepsy Res 32: 304 – 308.en_US
dc.identifier.citedreferenceUebachs M, Opitz T, Royeck M, Dickhof G, Horstmann MT, Isom LL, Beck H. ( 2010 ) Efficacy loss of the anticonvulsant carbamazepine in mice lacking sodium channel beta subunits via paradoxical effects on persistent sodium currents. J Neurosci 30: 8489 – 8501.en_US
dc.identifier.citedreferenceVervaeke K, Hu H, Graham LJ, Storm JF. ( 2006 ) Contrasting effects of the persistent Na + current on neuronal excitability and spike timing. Neuron 49: 257 – 270.en_US
dc.identifier.citedreferenceWang Y, Park KD, Salome C, Wilson SM, Stables JP, Liu R, Khanna R, Kohn H. ( 2011 ) Development and characterization of novel derivatives of the antiepileptic drug lacosamide that exhibit far greater enhancement in slow inactivation of voltage‐gated sodium channels. ACS Chem Neurosci 2: 90 – 106.en_US
dc.identifier.citedreferenceXu J, Kang N, Jiang L, Nedergaard M, Kang J. ( 2005 ) Activity‐dependent long‐term potentiation of intrinsic excitability in hippocampal CA1 pyramidal neurons. J Neurosci 25: 1750 – 1760.en_US
dc.identifier.citedreferenceYang YC, Hsieh JY, Kuo CC. ( 2009 ) The external pore loop interacts with S6 and S3‐S4 linker in domain 4 to assume an essential role in gating control and anticonvulsant action in the Na + channel. J Gen Physiol 134: 95 – 113.en_US
dc.identifier.citedreferenceYue C, Remy S, Su H, Beck H, Yaari Y. ( 2005 ) Proximal persistent Na + channels drive spike afterdepolarizations and associated bursting in adult CA1 pyramidal cells. J Neurosci 25: 9704 – 9720.en_US
dc.identifier.citedreferenceAndurkar SV, Stables JP, Kohn H. ( 1999 ) The anticonvulsant activities of N‐benzyl 3‐methoxypropionamides. Bioorg Med Chem 7: 2381 – 2389.en_US
dc.identifier.citedreferenceBrandt C, Heile A, Potschka H, Stoehr T, Löscher W. ( 2006 ) Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats. Epilepsia 47: 1803 – 1809.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1528-1167.2012.03675.x.pdf
Size:
484.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.